Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Neuroblastoma 1 Hepatoblastoma 1 Head and Neck Neoplasms 1 HER2 Positive Advanced Gastric Cancer 1 Basal Cell Carcinoma of the Head and Neck 1

Interventions

Cisplatin 8 Carboplatin 8 X-Rays 7 Specimen Handling 7 Phantoms, Imaging 7 Magnetic Resonance Spectroscopy 6 Cyclophosphamide 6 Vincristine 5 Nuclear Medicine Department, Hospital 5 Granulocyte Colony-Stimulating Factor 5 Etoposide 5 Doxorubicin 5 Biopsy 5 sodium thiosulfate 4 Melphalan 4 Irinotecan 4 Fluorouracil 4 fludarabine 3 Thiotepa 3 Oxaliplatin 3 Mesna 3 Gemcitabine 3 Filgrastim 3 Busulfan 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 pembrolizumab 2 palbociclib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hepatoblastoma × Tissue Banks × Clear all

NCT00228683 2013-11-26

Hepatoblastoma Biology Study and Tissue Bank

Emory University

Phase NA Withdrawn

Gastrointestinal

Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡